Personal information

Nuclear receptors, retinoic acid-related orphan receptor, RORgamma, Gli-similar, Glis1, Glis2, Glis3, RAP80, UIMC1, diabetes, obesity, JAZF1, TR4, polycystic kidney disease,
U.S. Minor Outlying Islands

Biography

Dr. Anton Jetten received his Ph.D in Microbiology from the University Nijmegen, The Netherlands. Following postdoctoral fellowships at the Massachusetts Institute of Technology and the Roche Institute of Molecular Biology, Dr. Jetten joined the NCI, NIH in 1980 and the NIEHS in 1982 as Principal Investigator and Head of the Cell Biology Section. He became Acting Chief in 2009 and Chief of the Immunity, Inflammation and Disease Laboratory (IIDL) in 2011, and since 2017 acts as Deputy Chief of IIDL. His research has been focusing on the study of the mechanism of action and the physiological functions of the retinoic acid-related orphan receptors (RORs) and GLI-similar (GLIS) transcription factor subfamilies as well as their roles in disease, particularly inflammation, autoimmune disease, metabolic syndrome, diabetes, and cystic kidney diseases. Dr. Jetten has published over 300 papers, to date, in scientific journals.

Activities

Employment (1)

National Institute of Environmental Health Sciences: Research Triangle Park, NC, US

1982-09 to present | Deputy Chief (Inflammation and Disease Laboratory )
Employment
Source: Self-asserted source
Anton M. Jetten

Peer review (11 reviews for 8 publications/grants)

Review activity for Advanced science. (2)
Review activity for Cell & bioscience. (1)
Review activity for Cell death and disease. (1)
Review activity for Endocrinology (2)
Review activity for Free radical biology & medicine. (2)
Review activity for Gene. (1)
Review activity for International journal of obesity. (1)
Review activity for Nature (1)